Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 222Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5AbbVie Inc

02 2Norvium

03 1Solvay

04 7Viatris

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

EPROSARTAN MESYLATE

Brand Name : TEVETEN

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 300MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1997-12-22

Application Number : 20738

Regulatory Info : DISCN

Registration Country : USA

Abbvie Company Banner

02

EPROSARTAN MESYLATE

Brand Name : TEVETEN

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1997-12-22

Application Number : 20738

Regulatory Info : DISCN

Registration Country : USA

Abbvie Company Banner

03

EPROSARTAN MESYLATE

Brand Name : TEVETEN

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 600MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1999-05-27

Application Number : 20738

Regulatory Info : DISCN

Registration Country : USA

Abbvie Company Banner

04

EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE

Brand Name : TEVETEN HCT

Dosage Form : TABLET;ORAL

Dosage Strength : 600MG;12.5MG

Packaging :

Approval Date : 2001-11-01

Application Number : 21268

Regulatory Info : DISCN

Registration Country : USA

Abbvie Company Banner

05

EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE

Brand Name : TEVETEN HCT

Dosage Form : TABLET;ORAL

Dosage Strength : 600MG;25MG

Packaging :

Approval Date : 2001-11-01

Application Number : 21268

Regulatory Info : DISCN

Registration Country : USA

Abbvie Company Banner

06

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

EPROSARTAN MESYLATE

Brand Name : EPROSARTAN MESYLATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 400MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202012

Regulatory Info : DISCN

Registration Country : USA

blank

07

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

EPROSARTAN MESYLATE

Brand Name : EPROSARTAN MESYLATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 600MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202012

Regulatory Info : DISCN

Registration Country : USA

blank

08

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Eprosartan Mesilate Hydrochlorothiazide

Brand Name : Co-Operation

Dosage Form : Film Coated Tablet

Dosage Strength : 600mg;12.5mg

Packaging :

Approval Date : 01/09/2006

Application Number : 20060112000231

Regulatory Info : Deregistered

Registration Country : Sweden

blank

09

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Eprosartan Mesilate Hydrochlorothiazide

Brand Name : Teveten Comp

Dosage Form : Film Coated Tablet

Dosage Strength : 600mg;12.5mg

Packaging :

Approval Date : 17/09/2004

Application Number : 20040607006108

Regulatory Info : Deregistered

Registration Country : Sweden

blank

10

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Hydrochlorothiazide; Eprosartan Mesylate Dihydrate

Brand Name : Navixen Plus

Dosage Form : Film Coated Tablet

Dosage Strength : 600MG; 12.5 MG

Packaging :

Approval Date : 2004-12-17

Application Number : 66512

Regulatory Info : Authorized

Registration Country : Spain

blank

11

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Hydrochlorothiazide; Eprosartan Mesylate Dihydrate

Brand Name : Regulaten Plus

Dosage Form : Film Coated Tablet

Dosage Strength : 600MG; 12.5 MG

Packaging :

Approval Date : 2005-01-13

Application Number : 66528

Regulatory Info : Authorized

Registration Country : Spain

blank

12

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Hydrochlorothiazide; Eprosartan Mesylate Dihydrate

Brand Name : Tevetens Plus

Dosage Form : Film Coated Tablet

Dosage Strength : 600MG; 12.5 MG

Packaging :

Approval Date : 2004-07-01

Application Number : 66206

Regulatory Info : Authorized

Registration Country : Spain

blank

13

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Hydrochlorothiazide; Eprosartan Mesylate Dihydrate

Brand Name : Futuran Plus

Dosage Form : Film Coated Tablet

Dosage Strength : 600MG; 12.5 MG

Packaging :

Approval Date : 2005-01-28

Application Number : 66568

Regulatory Info : Authorized

Registration Country : Spain

blank

14

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Eprosartan Mesylate Dihydrate

Brand Name : Regulate

Dosage Form : Film Coated Tablet

Dosage Strength : 600MG

Packaging :

Approval Date : 2000-12-04

Application Number : 63509

Regulatory Info : Authorized

Registration Country : Spain

blank

15

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Eprosartan Mesylate Dihydrate

Brand Name : Future

Dosage Form : Film Coated Tablet

Dosage Strength : 600MG

Packaging :

Approval Date : 2002-02-22

Application Number : 64578

Regulatory Info : Authorized

Registration Country : Spain

blank